Buy Dr Reddys Labs, says Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Dr Reddys Laboratories had a small correction and that correction may well be over and one should consider it for buying."

At 14:22 hrs Dr Reddys Laboratories was quoting at Rs 2,089.70, up Rs 24.50, or 1.19 percent. It has touched an intraday high of Rs 2,102.65 and an intraday low of Rs 2,060.10. The share touched its 52-week high Rs 2,150.90 and 52-week low Rs 1,555.00 on 13 May, 2013 and 19 June, 2012, respectively. Currently, it is trading 2.85 percent below its 52-week high and 34.39 percent above its 52-week low. Market capitalisation stands at Rs 35,490.73 crore.